URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led pathways? As an early trainee in urology, I used to learn about transrectal ...

Prostate cancer is characterized by increased microvascularization and abnormal vascular architecture, which can be visualized using advanced ultrasound modalities. Microvascular imaging (MVI) and ...

IsoPSA Test Evaluates Prostate Cancer-Specific Structural Variants of the PSA Protein to Aid in the Diagnosis of High-Grade Prostate Cancer CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Study data, published in JAMA and presented at EMUC 2025, suggest ExactVu is potential MRI alternative for image-guided prostate biopsy “These results are a game-changer for urologists and patients, ...

If you're experiencing symptoms that may indicate prostate cancer, here's what else could be causing them getty Several medical conditions can mimic prostate cancer, causing many of the same symptoms, ...

Enhanced Detection of Druggable Mutations in Non–Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor Tissue Our study found that PZ biopsies ...

The episode also underscores the role of artificial intelligence in prostate imaging. In this episode of Pearls & Perspectives, Amy Pearlman, MD, speaks with Dan Sperling, MD, DABR, a board-certified ...